“…Nonsteroidal anti-inflammatory drugs (NSAIDs), such as indomethacin (IMC) and naproxen, are widely used for the treatment of various acute and chronic inflammation by inhibiting the activity of the cyclooxygenase enzymes (COX) involved in the synthesis of prostaglandins, which are key biological mediators in regulating inflammation. − However, the efficacy of NSAIDs is undermined by their poor aqueous solubility in water, low in vivo absorption, weak bioavailability, and, moreover, serious side effects at high dosage, such as gastrointestinal irritation, bronchospasm, thrombosis, and nephrotoxicity. , As a result, it is highly desirable to overcome these limitations of NSAIDs without compromising their anti-inflammatory activities. Recent studies have shown that the utilization of the carboxylic acid moieties within NSAIDs for incorporating other functional groups via a 1,4-butyldiamine linker is optimal for improving the properties of NSAIDs without significantly reducing their anti-inflammatory effects. , Interestingly, some of the NSAIDs have been reported to reduce M1 macrophage polarization. , During inflammation, excessive reactive oxygen species (ROS) are generated at inflammatory sites, which is one of the most devastating effects of inflammation. − Therefore, attenuating the level of ROS by antioxidants has become another popular strategy for relieving inflammation. For example, amifostine (AMF) has been utilized to ease inflammation by scavenging ROS .…”